Abstract
Receptor-interacting protein (RIP) has been implicated in the induction of death receptor-mediated, nonapoptotic cell death. However, the mechanisms remain to be elucidated. Here we show that tumor necrosis factor alpha induced RIP-dependent inhibition of adenine nucleotide translocase (ANT)-conducted transport of ADP into mitochondria, which resulted in reduced ATP and necrotic cell death. The inhibition of ADP/ATP exchange coincided with the loss of interaction between ANT and cyclophilin D and the inability of ANT to adopt the cytosolic conformational state, which prevented cytochrome c release. Neither overexpression of Bcl-xL nor inhibition of reactive oxygen species prevented necrosis. In contrast, the ectopic expression of ANT or cyclophilin D was effective at preventing cell death. These observations demonstrate a novel mechanism initiated through death receptor ligation and mediated by RIP that results in the suppression of ANT activity and necrosis.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adenosine Diphosphate / metabolism*
-
Adenosine Triphosphate / metabolism*
-
Amino Acid Chloromethyl Ketones / metabolism
-
Amino Acid Chloromethyl Ketones / pharmacology
-
Biological Transport / drug effects
-
Cell Death / drug effects
-
Cell Death / physiology
-
Cells, Cultured
-
Cyclophilins / pharmacology
-
Cysteine / metabolism
-
Cysteine Proteinase Inhibitors / metabolism
-
Cysteine Proteinase Inhibitors / pharmacology
-
Humans
-
Intracellular Membranes
-
Membrane Potentials / drug effects
-
Mitochondria / drug effects
-
Mitochondria / metabolism
-
Mitochondrial ADP, ATP Translocases / drug effects
-
Mitochondrial ADP, ATP Translocases / genetics
-
Mitochondrial ADP, ATP Translocases / metabolism
-
Necrosis*
-
Peptidyl-Prolyl Isomerase F
-
Permeability
-
Protein Serine-Threonine Kinases / antagonists & inhibitors
-
Protein Serine-Threonine Kinases / genetics
-
Protein Serine-Threonine Kinases / metabolism*
-
Reactive Oxygen Species / metabolism
-
Receptor-Interacting Protein Serine-Threonine Kinases
-
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins / antagonists & inhibitors
-
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins / genetics
-
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins / metabolism*
-
Tumor Necrosis Factor-alpha / pharmacology
-
bcl-X Protein / genetics
-
bcl-X Protein / metabolism
Substances
-
Amino Acid Chloromethyl Ketones
-
BCL2L1 protein, human
-
Peptidyl-Prolyl Isomerase F
-
Cysteine Proteinase Inhibitors
-
Reactive Oxygen Species
-
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins
-
Tumor Necrosis Factor-alpha
-
bcl-X Protein
-
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
-
Adenosine Diphosphate
-
Adenosine Triphosphate
-
Mitochondrial ADP, ATP Translocases
-
Protein Serine-Threonine Kinases
-
RIPK1 protein, human
-
Receptor-Interacting Protein Serine-Threonine Kinases
-
Cyclophilins
-
Cysteine